In contrast to paper solutions, electronic Clinical Outcome Assessment (eCOA) demonstrates strengths such as: Accuracy
We spoke at DMB on “The shift to ePRO collection at home: Strategies to preserve data quality and re-think compliance”
Date: November 22
Time: 11:15AM CET
Location: Paris, France
Presentation in French
Evolution in data management practices
- Optimization of technological controls use
- ePRO compliance metrics & responsibility of compliance between the site, patient, and technology in the new DCT model
Decentralized clinical trials seek to offer more flexibility to patients by allowing them to complete some clinical trial assessments from their own home. Technical innovations have given patients the ability to complete PROs from their own phone, computer, or via phone interview with trained site staff personnel when needed, but how can we preserve data quality and meet compliance requirements with the high variability of data collection methods? How to face the increasing quantities of data collected and the rising complexity of regulatory standards?
Want to learn more and discover our solution? Meet us at the DMB 25th Annual Conference!
Early phase clinical research (phase 1 and 2a) focuses on characterizing the behavior of the
In a clinical trials environment that is moving increasingly towards digitalization and decentralization, it remains
In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare.
In this first episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Last update : 9 November 2022